Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
123
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hepatitis 2011 OD 1R43AI088940-01 Development of a Listeria monocytogenes - based therapeutic HBV vaccine LAUER, PETER ADURO BIOTECH CA $188,315
Hepatitis 2011 NIDDK 5F32DK083893-02 Pathogenic Mechanisms of Fatty Liver Disease SIDDIQUI, MOHAMMAD NORTHWESTERN UNIVERSITY AT CHICAGO IL $54,734
Hepatitis 2011 NIA 1K01AG034999-01A1 Aging with Chronic Viral Infections and the Impact on Innate Immune Responses STOUT-DELGADO, HEATHER LOVELACE BIOMEDICAL & ENVIRONMENTAL RES NM $137,430
Hepatitis 2011 NIAID 5R01AI072613-05 Identification and characterization of cellular factors involved in HCV entry RICE, CHARLES ROCKEFELLER UNIVERSITY NY $406,225
Hepatitis 2011 NIMH 5R01MH079752-05 Role of evolving white matter damage in neurocognitive effects of HIV and HCV JERNIGAN, TERRY UNIVERSITY OF CALIFORNIA SAN DIEGO CA $344,149
Hepatitis 2011 NIAID 5R01AI078195-03 Chemokines in Autoimmune Hepatitis GORHAM, JAMES DARTMOUTH COLLEGE NH $391,795
Hepatitis 2011 NIAID 5R01AI075099-04 Role of HCV p7 and NS2 in infectious virus production RICE, CHARLES ROCKEFELLER UNIVERSITY NY $414,092
Hepatitis 2011 NIAID 5R01AI020001-28 Pathogenesis of Liver Disease in Hepatitis CHISARI, FRANCIS SCRIPPS RESEARCH INSTITUTE CA $644,772
Hepatitis 2011 NCI 5R01CA126807-04 HCV genetic variation and hepatocellular carcinoma TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $266,288
Hepatitis 2011 NIGMS 5SC2AI083926-03 Synthesis of Carbocyclic Formycin Analogues as Antiviral Agents SERBESSA, TESFAYE ELIZABETH CITY STATE UNIVERSITY NC $127,071
Hepatitis 2011 NIAID 5R01AI071084-03 Probing the antibody response to HCV to facilitate rational immunogen design BURTON, DENNIS SCRIPPS RESEARCH INSTITUTE CA $618,839
Hepatitis 2011 NIEHS 5R01ES016313-04 The Environment as a Variable to Calibrate Mouse Models of Human Disease ESSIGMANN, JOHN MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $565,382
Hepatitis 2011 NCI 5R01CA132962-02 A Genetic Screen for HCC Genes LARGAESPADA, DAVID UNIVERSITY OF MINNESOTA TWIN CITIES MN $302,919
Hepatitis 2011 NIAID 5R01AI040696-14 Regulation of HBV Replication by the Immune System GUIDOTTI, LUCA SCRIPPS RESEARCH INSTITUTE CA $464,322
Hepatitis 2011 NIDDK 5R01DK077704-04 Viral Hepatitis C and Lipid Homeostasis SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $321,779
Hepatitis 2011 NIDDK 5R01DK078686-04 Genetic and epigenetic regulation of Hepatitis B contributes to liver cancer TORBENSON, MICHAEL JOHNS HOPKINS UNIVERSITY MD $341,564
Hepatitis 2011 NIAID 5R37AI047367-12 HCV-specific T cell response WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $665,354
Hepatitis 2011 NIEHS 5K01ES017105-02 Ubiquitous pollutant acrolein inhibits IFN?? antiviral signaling: relevance to HC JOSHI-BARVE, SWATI UNIVERSITY OF LOUISVILLE KY $131,085
Hepatitis 2011 NIAID 5R01AI020720-28 Mechanisms of Chronic Hepatitis B Infection and Therapeutic Vaccines MILICH, DAVID VACCINE RESEARCH INSTITUTE OF SAN DIEGO CA $777,154
Hepatitis 2011 NIAID 5R01AI073335-04 RNA-dependent RNA Synthesis by the Hepatitis C Virus KAO, CHENG INDIANA UNIVERSITY BLOOMINGTON IN $315,195
Hepatitis 2011 NIAID 5R37AI047365-12 Structure and Function of the Hepatitis C Virus Genome SARNOW, PETER STANFORD UNIVERSITY CA $435,304
Hepatitis 2011 NIAAA 5R44AA018922-03 Heptax for Alcoholic Liver Disease PASHKOW, FREDRIC CARDAX PHARMACEUTICALS, INC. HI $484,221
Hepatitis 2011 NCRR 5K26RR023976-03 Mouse Immunopathology LIU, CHEN UNIVERSITY OF FLORIDA FL $161,563
Hepatitis 2011 NIAID 5R01AI087746-02 Cyclophilins, Cyclophilin Inhibitors and Hepatitis C GALLAY, PHILIPPE SCRIPPS RESEARCH INSTITUTE CA $470,003
Hepatitis 2011 NIAID 5R01AI087917-02 HCV NS4B: Translating molecular virology into novel antiviral therapies GLENN, JEFFREY STANFORD UNIVERSITY CA $416,837
Hepatitis 2011 NIDA 5R01DA024598-04 Social networks and HIV risk among rural drug users HAVENS, JENNIFER UNIVERSITY OF KENTUCKY KY $577,058
Hepatitis 2011 NCI 5R01CA056533-19 Viral and Cellular Determinants of Hepatitis B Virus Pathogenesis SCHNEIDER, ROBERT NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $411,038
Hepatitis 2011 NICHD 1R01HD062489-01A1 Pediatric Adverse Drug Reactions in NASH CHERRINGTON, NATHAN UNIVERSITY OF ARIZONA AZ $321,938
Hepatitis 2011 NIDA 5R01DA012568-13 Incidence of HIV Infection in a Cohort of IV Drug Users MEHTA, SHRUTI JOHNS HOPKINS UNIVERSITY MD $1,036,759
Hepatitis 2011 NIGMS 5R01GM081420-03 Characterizing RNA-metal binding by Raman spectroscopy CAREY, PAUL CASE WESTERN RESERVE UNIVERSITY OH $307,172
Hepatitis 2011 NCI 5R01CA120719-03 Markers for HCV-related HCC: plasma profiling, targeted strategies and validation BERETTA, LAURA FRED HUTCHINSON CANCER RESEARCH CENTER WA $354,244
Hepatitis 2011 NIAID 5R01AI088001-03 Antiviral potential of helicase inhibitors FRICK, DAVID UNIVERSITY OF WISCONSIN MILWAUKEE WI $365,558
Hepatitis 2011 NIAID 5K08AI077713-04 HCV diversity and resistance analyzed by DNA bar coding and pyrosequencing WANG, GARY UNIVERSITY OF FLORIDA FL $131,652
Hepatitis 2011 NIAID 5R01AI087925-02 Molecular determinants of hepatitis C virus assembly LINDENBACH, BRETT YALE UNIVERSITY CT $409,613
Hepatitis 2011 NIAID 5R01AI069142-05 Immune Mechanisms of HCV Persistence and Pathogenesis SUN, JIAREN UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $326,663
Hepatitis 2011 NIDDK 5K23DK083439-02 Non-invasive evaluation of Non-alcoholic Steatohepatitis LAI, MICHELLE BETH ISRAEL DEACONESS MEDICAL CENTER MA $177,444
Hepatitis 2011 NIDA 5R01DA022170-04 Diffusion of HIV-1 among Drug Using Men in SE Asia CLATTS, MICHAEL UNIVERSITY OF PUERTO RICO MED SCIENCES PR $362,477
Hepatitis 2011 NIDDK 1R01DK090313-01 Regulation of Hepatic Steatosis by an ER Stress-Inducible Transcription Factor CR ZHANG, KEZHONG WAYNE STATE UNIVERSITY MI $380,000
Hepatitis 2011 NIGMS 1R01GM095923-01 Coupling of structure and dynamics in RNA catalysis GOLDEN, BARBARA PURDUE UNIVERSITY WEST LAFAYETTE IN $327,696
Hepatitis 2011 NHLBI 1R01HL105704-01 Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing CHIU, CHARLES UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $596,655
Hepatitis 2011 NIAID 1R01AI091953-01 Viral and Cellular Determinants of HCV Assembly LUO, GUANGXIANG UNIVERSITY OF KENTUCKY KY $371,250
Hepatitis 2011 NCI 5R01CA057973-18 Structure and function of the HCV RNA replicase RICE, CHARLES ROCKEFELLER UNIVERSITY NY $376,233
Hepatitis 2011 NIAID 1R21AI092074-01 Transgenic mouse models of HCV infection and replication LUO, GUANGXIANG UNIVERSITY OF KENTUCKY KY $185,625
Hepatitis 2011 NIAID 5R01AI060389-10 The Host Response to Hepatitis C Virus GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $375,141
Hepatitis 2011 NIAID 5R01AI074982-04 Molecular Mechanism of Hepadnavirus Persistence HU, JIANMING PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $297,389
Hepatitis 2011 NIAID 5R01AI050611-08 A Chicken Model to Study Hepatitis E Virus Pathogenesis MENG, XIANG-JIN VIRGINIA POLYTECHNIC INST AND ST UNIV VA $310,692
Hepatitis 2011 NIAID 5R01AI074667-04 Mechanism of Hepatitis E Virus Replication and Pathogenesis MENG, XIANG-JIN VIRGINIA POLYTECHNIC INST AND ST UNIV VA $382,209
Hepatitis 2011 NIAID 5U01AI064002-07 Chemoprophylaxis for HIV Prevention in Men GRANT, ROBERT J. DAVID GLADSTONE INSTITUTES CA $4,388,511
Hepatitis 2011 NIAID 5R01AI072012-05 New Antiviral Therapies for Hepatitis C Infection HERMANN, THOMAS UNIVERSITY OF CALIFORNIA SAN DIEGO CA $353,867
Hepatitis 2011 NIDA 5R01DA011602-13 HIV Disease Outcomes in Drug Users in Clinical Practice MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $702,056
Hepatitis 2011 NIDA 5R21DA028645-02 Increasing Viral Testing in the Emergency Department (InVITED) MERCHANT, ROLAND RHODE ISLAND HOSPITAL RI $171,128
Hepatitis 2011 NIAID 5R01AI076558-03 Orally Active Nucleoside Phosphonates for Hepatitis C Virus SCHOOLEY, ROBERT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $587,665
Hepatitis 2011 NIDDK 5R01DK080711-04 Hepatitis C Virus Quasispecies in the Resistance to Antiviral Therapy FAN, XIAOFENG SAINT LOUIS UNIVERSITY MO $288,149
Hepatitis 2011 NIDA 5R01DA016147-08 HBV Prevention for Homeless at Risk for HBV/HCV/HIV NYAMATHI, ADELINE UNIVERSITY OF CALIFORNIA LOS ANGELES CA $618,727
Hepatitis 2011 NIAID 5R01AI069285-06 Role of TLR3 Signaling in Control of HCV LI, KUI UNIVERSITY OF TENNESSEE HEALTH SCI CTR TN $249,022
Hepatitis 2011 NINR 5R21NR011132-02 Feasibility of a HCV Decision-Making Intervention among HIV-Infected Adults BOVA, CAROL UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $244,283
Hepatitis 2011 NIAID 5K08AI075031-04 The Pathogenesis of Autoimmunity in Hepatitis C Virus Infection CHARLES, EDGAR ROCKEFELLER UNIVERSITY NY $140,400
Hepatitis 2011 NIDA 5R01DA024553-03 Treatment Study Using Depot Naltrexone(1/6)Philadelphia Coord/Data Mgmt Site O'BRIEN, CHARLES UNIVERSITY OF PENNSYLVANIA PA $587,187
Hepatitis 2011 NIDDK 1R01DK087977-01A1 The Role of Mitochondrial Dysfunction in Non-Alcoholic Fatty Liver Disease BROWNING, JEFFREY UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $572,237
Hepatitis 2011 NIDDK 1R01DK088114-01A1 Effects of recombinant human leptin in nonalcoholic fatty liver disease (NAFLD) ORAL, ELIF UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $387,500
Hepatitis 2011 NIDDK 1R01DK085252-01A1 LPS binding to TLR4 regulates hepatic stellate cell activation and fibrosis SEKI, EKIHIRO UNIVERSITY OF CALIFORNIA SAN DIEGO CA $386,250
Hepatitis 2011 NIAID 5R43AI088919-02 A Therapeutic Vaccine for Chronic Hepatitis B MILICH, DAVID VLP BIOTECH, INC. CA $300,000
Hepatitis 2011 NIAID 2R01AI069000-06 Roles for microRNA-122 in hepatitis C virus RNA amplification SARNOW, PETER STANFORD UNIVERSITY CA $390,924
Hepatitis 2011 NIDDK 1R01DK090794-01A1 Heat Shock Protein Synthesis Inhibitor Treatment of Hepatitis C Viral Infection FRENCH, SAMUEL UNIVERSITY OF CALIFORNIA LOS ANGELES CA $385,000
Hepatitis 2011 NIDDK 1K23DK085150-01A1 Non-Alcoholic Fatty Liver Disease and Obstructive Sleep Apnea: Mechanistic Links SUNDARAM, SHIKHA UNIVERSITY OF COLORADO DENVER CO $180,360
Hepatitis 2011 NIAID 5R21AI088351-02 HIV status and reproductive aging affect liver fibrosis in HIV/HCV infected women PETERS, MARION UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $204,372
Hepatitis 2011 NIDDK 2R01DK072017-05A1 Obesity and Hepatic Steatosis PAGLIASSOTTI, MICHAEL COLORADO STATE UNIVERSITY-FORT COLLINS CO $292,481
Hepatitis 2011 NCI 5R21CA149908-02 Engineered lymphocytes for the treatment of hepatocellular carcinoma KAPLAN, DAVID UNIVERSITY OF PENNSYLVANIA PA $159,497
Hepatitis 2011 NIAID 1R21AI088516-01A1 Natural Phenotypic Diversity of HCV NS3/4A Protease GRETCH, DAVID UNIVERSITY OF WASHINGTON WA $222,956
Hepatitis 2011 NIDDK 5R01DK074673-04 Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos KHALILI, MANDANA UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $434,878
Hepatitis 2011 NCI 5R01CA037232-27 HEPADNAVIRUS ASSOCIATED HEPATOCELLULAR CARCINOMA ROGLER, CHARLES ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $491,862
Hepatitis 2011 NIDDK 5K08DK083774-02 Thioredoxin Inhibitory Protein in Chronic Liver Disease HAMILTON, JAMES JOHNS HOPKINS UNIVERSITY MD $155,785
Hepatitis 2011 NIDDK 5R01DK083356-02 Defining the intrahepatic immune response to hepatitis C virus GRAKOUI, ARASH EMORY UNIVERSITY GA $359,206
Hepatitis 2011 NIDA 5R44DA023722-03 Using CAI to Enhance Drug Tx Staff HCV Knowledge and Communication Skills LIBERTY, HILARY SOCIAL SCIENCES INNOVATIONS CORPORATION NY $468,485
Hepatitis 2011 NIDDK 5R01DK076852-05 The Lysosomal-Mitochondrial Axis in Nonalcoholic Fatty Liver Disease FELDSTEIN, ARIEL CLEVELAND CLINIC LERNER COL/MED-CWRU OH $273,793
Hepatitis 2011 NIDDK 5R01DK063222-08 Role of NK in Regulation of anti-viral T cell immunity HAHN, YOUNG UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $252,425
Hepatitis 2011 NIDA 5R01DA029512-02 Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV Prevention EDLIN, BRIAN SUNY DOWNSTATE MEDICAL CENTER NY $679,384
Hepatitis 2011 NIAID 5R01AI076535-04 Combination therapies for chronic HBV, liver disease and cancer FEITELSON, MARK TEMPLE UNIVERSITY PA $347,054
Hepatitis 2011 NCI 5R01CA131133-04 Viral Vaccine Vectors to Prevent Hepatocellular Carcinoma ROBEK, MICHAEL YALE UNIVERSITY CT $229,117
Hepatitis 2011 NLM 5G13LM010000-03 Human Hepatitis Experiments in the United States, 1942-1972 HALPERN, SYDNEY UNIVERSITY OF ILLINOIS AT CHICAGO IL $78,500
Hepatitis 2011 NIAID 5K01AI070001-05 Risk factors and prediction of liver disease in HIV/HCV LO RE, VINCENT UNIVERSITY OF PENNSYLVANIA PA $133,029
Hepatitis 2011 NIDDK 5R01DK072187-05 Genetics of Nonalcoholic Fatty Liver Disease (NAFLD) ERICKSON, SANDRA NORTHERN CALIFORNIA INSTITUTE RES & EDUC CA $302,750
Hepatitis 2011 NIEHS 5R01ES005116-20 Biological Markers of Aflatoxin Exposure and Methylation SANTELLA, REGINA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $417,806
Hepatitis 2011 NCI 5R01CA055578-16 Role of PreS2 Mutants in Pathogenesis of Chronic Hepatitis B PULLIAM, LYNN NORTHERN CALIFORNIA INSTITUTE RES & EDUC CA $272,098
Hepatitis 2011 NIDA 5R01DA023408-05 Environmental Factors in HIV Transmission among Suburban IDUs HEIMER, ROBERT YALE UNIVERSITY CT $529,832
Hepatitis 2011 NCI 5R01CA127481-04 Hepatocarcinogenesis Secondary to Hepatitis C DASH, SRIKANTA TULANE UNIVERSITY OF LOUISIANA LA $272,731
Hepatitis 2011 NIAID 2R44AI074256-02 Chemical Stabilization of shRNAs and their development as hepatitis C drugs JOHNSTON, BRIAN SOMAGENICS, INC. CA $1,000,000
Hepatitis 2011 NCRR 2R42DK082087-02A1 Automated quantification of lipid droplets in fatty liver tissue sections MCDONOUGH, PATRICK VALA SCIENCES, INC. CA $733,790
Hepatitis 2011 NIMH 5F31MH087226-02 Emotion and Relationships Underlying HIV/HCV Risk Among Incarcerated Women YARD, SAMANTHA UNIVERSITY OF WASHINGTON WA $41,800
Hepatitis 2011 NIAAA 2R44AA016712-03A2 Novel Catalytic MetalloDrug Targeting IRES RNA for Treatment of HCV Infection COWAN, ADA METALLOPHARM, LLC OH $844,040
Hepatitis 2011 NIAID 1R43AI085739-01A1 Improved Detection Of Drug-Resistance By Hepatitis B Virus REN, XIANGDONG RENIGUARD LIFE SCIENCES, INC. PA $300,000
Hepatitis 2011 NIDDK 5R01DK065122-08 Role of SH2-B in Glucose Metabolism RUI, LIANGYOU UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $351,718
Hepatitis 2011 NINDS 5F31NS070706-02 Diffusion Tensor Imaging and Neuropsychological Outcomes in HIV/HCV Co-infection HEAPS, JODI UNIVERSITY OF MISSOURI-ST. LOUIS MO $30,000
Hepatitis 2011 NIAID 5R01AI080703-02 Hepatitis C Virus Trafficking in Infected Hepatocytes RANDALL, GLENN UNIVERSITY OF CHICAGO IL $342,700
Hepatitis 2011 NIAID 5R37AI028731-22 Noncarbohydrate Approaches to AntiAIDS Nucleosides LIOTTA, DENNIS EMORY UNIVERSITY GA $347,696
Hepatitis 2011 NIAID 5R01AI085051-02 Drug Resistance in HCV NS3/4A - Inhibitor binding versus substrate recognition SCHIFFER, CELIA UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $407,138
Hepatitis 2011 NIAID 5K23AI066983-04 HIV and Hepatitis B Coinfection: Hepatitis B Genotype, Resistance and Outcomes BHATTACHARYA, DEBIKA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $123,390
Hepatitis 2011 NIDDK 5K01DK087776-02 Regulation of lipid metabolism by macroautophagy SINGH, RAJAT ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $136,961
Hepatitis 2011 NIDDK 5F30DK088385-02 The Molecular Mechanism of Antibody Neutralization of Hepatitis C Virus SABO, MICHELLE WASHINGTON UNIVERSITY MO $46,800
Hepatitis 2011 NIAID 5R21AI084090-02 The role of hepatitis C virus 5' untranslated region in virus morphogenesis DASGUPTA, ASIM UNIVERSITY OF CALIFORNIA LOS ANGELES CA $185,069
Hepatitis 2011 NIDA 5K01DA024654-04 Antiviral Role of APOBEC3 in HIV/HCV Coinfected Patients PILLAI, SATISH UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $180,360
Hepatitis 2011 NIMHD 5R24MD002756-04 CBPR on Hepatitis B Intervention for Underserved Korean Americans MA, GRACE TEMPLE UNIVERSITY PA $447,370
Hepatitis 2011 NIDDK 5K24DK066144-07 Mentoring Junior Faculty: Viral hepatitis Clinical Research FRIED, MICHAEL UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $162,645
Hepatitis 2011 NIDDK 5K24DK078154-05 Epidemiology and Outcomes of Digestive and Liver Diseases: A Mentoring Program EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE TX $120,453
Hepatitis 2011 NIDA 5R01DA016017-09 Acute Hepatitis C Infection in Young Injectors PAGE, KIMBERLY UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $992,772
Hepatitis 2011 NCI 5R01CA122295-05 Androgen Receptor Roles in Liver Cancer Incidence and Progression CHANG, CHAWNSHANG UNIVERSITY OF ROCHESTER NY $283,822
Hepatitis 2011 NIDDK 5R01DK084139-02 Hepatitis C: E2 Molecular Mechanisms BUCK, MARTINA VETERANS MEDICAL RESEARCH FDN/SAN DIEGO CA $330,474
Hepatitis 2011 NIDDK 5R01DK053792-10 Liver Disease in Obesity DIEHL, ANNA MAE DUKE UNIVERSITY NC $320,463
Hepatitis 2011 NIDDK 5R01DK088076-02 Role of microRNA-122 in hepatocarcinogenesis using conditional knock out mice GHOSHAL, KALPANA OHIO STATE UNIVERSITY OH $313,273
Hepatitis 2011 NCI 5R01CA123544-05 Biomarker for Hepatocellular Carcinoma WANDS, JACK RHODE ISLAND HOSPITAL RI $231,313
Hepatitis 2011 NIAID 5R01AI056289-10 Recombinant Attenuated Salmonella Vaccines for Humans CURTISS, ROY ARIZONA STATE UNIVERSITY-TEMPE CAMPUS AZ $373,663
Hepatitis 2011 NIAID 5K08AI069989-05 An in vitro system to study antiviral strategies against Hepatitis C virus WYLES, DAVID UNIVERSITY OF CALIFORNIA SAN DIEGO CA $116,370
Hepatitis 2011 NIAID 5R01AI079043-02 Innate Control of Hepatitis C Virus Infection: Antiviral and Evasion Mechanisms CHISARI, FRANCIS SCRIPPS RESEARCH INSTITUTE CA $470,003
Hepatitis 2011 NIDA 5R01DA022914-04 Couples-Based HIV/STI Prevention for Injecting Drug Users in Kazakhstan EL-BASSEL, NABILA COLUMBIA UNIV NEW YORK MORNINGSIDE NY $650,621
Hepatitis 2011 NCI 5K07CA132955-02 HBV reactivation among cancer patients receiving chemotherapy HWANG, JESSICA UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $140,399
Hepatitis 2011 NIDA 2R25DA013582-11 Clinical Addiction Research and Education Program SAMET, JEFFREY BOSTON MEDICAL CENTER MA $377,136
Hepatitis 2011 NIAID 5R03AI085226-02 Development of real time fluorescence-based assays for elucidating HCV entry dyna UPRICHARD, SUSAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $77,715
Hepatitis 2011 NIAID 5R01AI081987-02 Investigating the Catalytic Mechanism of the HDV Ribozyme PICCIRILLI, JOSEPH UNIVERSITY OF CHICAGO IL $375,456
Hepatitis 2011 NIDA 5R01DA021550-04 HCV Transmission among Young IDUs in NYC EDLIN, BRIAN SUNY DOWNSTATE MEDICAL CENTER NY $829,591
Hepatitis 2011 NIDDK 5K08DK088951-02 Examination of the Relationship of Host Cholesterol Biosynthesis to Chronic HCV I PENG, LEE MASSACHUSETTS GENERAL HOSPITAL MA $158,949
Hepatitis 2011 NIAID 5R01AI077688-03 The Biophysics of Virus Capsid Assembly ZLOTNICK, ADAM INDIANA UNIVERSITY BLOOMINGTON IN $292,104
Hepatitis 2011 NIDA 5K23DA023467-04 Chronic Pain and Substance Use in Patients with Hepatitis C MORASCO, BENJAMIN OREGON HEALTH AND SCIENCE UNIVERSITY OR $166,684
Hepatitis 2011 NIDDK 5R01DK088375-02 Accurate Measurement of Renal Function in Cirrhosis LEE, VIVIAN NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $585,270
Hepatitis 2011 NIDDK 5R21DK083560-02 FUSE Binding Protein As a Cellular Effector of HCV Replication PANDEY, VIRENDRA UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL NJ $231,660
Hepatitis 2011 NIAID 5R01AI052065-08 HCV and HIV Progression in Women on HAART KOVACS, ANDREA UNIVERSITY OF SOUTHERN CALIFORNIA CA $576,980
Hepatitis 2011 NCI 5R21CA152078-02 Vaccine-Preventable Cancer Behavior Measurement among Southeast Asian Americans LEE, HAEOK UNIVERSITY OF MASSACHUSETTS BOSTON MA $191,624
Hepatitis 2011 NIDA 5R01DA009832-15 Intervention to Reduce Injection Drug Use BOOTH, ROBERT UNIVERSITY OF COLORADO DENVER CO $492,670
Hepatitis 2011 NIDDK 5K23DK080888-04 Biological Determinants of Steatohepatitis after Adolescent Bariatric Surgery XANTHAKOS, STAVRA CHILDREN'S HOSPITAL MEDICAL CENTER CINCI OH $177,444
Hepatitis 2011 NIDA 5R01DA015999-07 Treatment of recently acquired hepatitis C virus infection DORE, GREGORY UNIVERSITY OF NEW SOUTH WALES AUSTRA $355,137
Hepatitis 2011 NIDA 5R01DA027213-03 Health Promotion Coaching/Vaccine for Homeless Parolees NYAMATHI, ADELINE UNIVERSITY OF CALIFORNIA LOS ANGELES CA $644,337
Hepatitis 2011 NIDA 5K23DA027367-02 HCV and Pain in Substance Users With and Without HIV TSUI, JUDITH BOSTON MEDICAL CENTER MA $171,369
Hepatitis 2011 NIAAA 5R37AA009300-16 Lipid Aldehyde and Ethanol Induced Liver Damage PETERSEN, DENNIS UNIVERSITY OF COLORADO DENVER CO $406,791
Hepatitis 2011 NIDA 5R01DA024563-05 Innate Immune Defense Against HCV and HIV: The Chimeric Mouse Model GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $381,235
Hepatitis 2011 NIAID 5K01AI073193-05 Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs LINAS, BENJAMIN MASSACHUSETTS GENERAL HOSPITAL MA $136,375
Hepatitis 2011 NIAID 5R01AI090055-02 Simianizing hepatitis C: Defining the species-tropism of a hepatotropic virus RICE, CHARLES ROCKEFELLER UNIVERSITY NY $426,849
Hepatitis 2011 NIAID 5K08AI083785-02 Characterization of a host hepatocyte factor that regulates HCV replication TAI, ANDREW UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $132,300
Hepatitis 2011 NIDA 5R01DA016065-09 HCV Disease Management in HIV- HCV Coinfected IDUs SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $417,799
Hepatitis 2011 NIGMS 5R01GM085117-04 The Role of Arginine Methyltransferases in Interferon Signaling MOWEN, KERRI SCRIPPS RESEARCH INSTITUTE CA $371,458
Hepatitis 2011 NIDA 5R01DA023857-04 At Risk Hispanic Gangs: Long-Term Consequences for Hiv, Hepatitis and STI VALDEZ, AVELARDO UNIVERSITY OF HOUSTON TX $551,285
Hepatitis 2011 NIDDK 1R01DK091601-01 Genetic determinants of NAFLD severity and progression DISTEFANO, JOHANNA TRANSLATIONAL GENOMICS RESEARCH INST AZ $739,560
Hepatitis 2011 NIDDK 5R01DK083380-02 Technical Development of Quantitative Biomarkers of Fatty Liver Disease with MRI REEDER, SCOTT UNIVERSITY OF WISCONSIN MADISON WI $298,680
Hepatitis 2011 NIDDK 5K08DK066032-05 Mechanisms of Non-Alcoholic Steatohepatitis RINELLA, MARY NORTHWESTERN UNIVERSITY AT CHICAGO IL $126,144
Hepatitis 2011 NIDA 5K23DA022454-04 Directly Observed Hepatitis C Treatment in Methadone Clinics LITWIN, ALAIN ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $182,557
Hepatitis 2011 NIAID 5R01AI083113-02 HCV resolution correlates with patterned KIR expressions on lymphocytes. RYAN, JAMES UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $405,307
Hepatitis 2011 NCI 5R21CA153147-02 Role of Autotaxin in HCV-associated Hepatocellular Carcinoma KAUSHIK-BASU, NEERJA UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL NJ $197,473
Hepatitis 2011 NIAID 5R01AI089826-02 Structure and function of the HCV replication complex PYLE, ANNA YALE UNIVERSITY CT $591,890
Hepatitis 2011 NIAID 5K24AI078884-04 Complications of Chronic Viral Infections GLESBY, MARSHALL WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $182,478
Hepatitis 2011 NIDDK 5K01DK082613-03 Host-pathogen interactions in hepatitis C virus replication BRADRICK, SHELTON DUKE UNIVERSITY NC $110,664
Hepatitis 2011 NIAID 5R01AI076357-04 A Murine Model of Chronic Autoimmune Hepatitis and Liver Fibrosis ZHONG, XIAOPING DUKE UNIVERSITY NC $305,791
Hepatitis 2011 NICHD 5R01HD040787-12 Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth CAPRIO, SONIA YALE UNIVERSITY CT $369,280
Hepatitis 2011 NIDDK 5K23DK082621-03 Concentration-Controlled Ribavirin for the Treatment of Patients with Chronic HVC KISER, JENNIFER UNIVERSITY OF COLORADO DENVER CO $167,837
Hepatitis 2011 NIAID 5R01AI087176-02 Visceral Adiposity, HIV, and HCV: Biologic Mediators of Hepatic Steatosis TIEN, PHYLLIS NORTHERN CALIFORNIA INSTITUTE RES & EDUC CA $540,263
Hepatitis 2011 NCI 1R21CA159047-01 Serum microRNA signature as prospective HCC biomarker in HBV patients YANG, HUSHAN THOMAS JEFFERSON UNIVERSITY PA $202,275
Hepatitis 2011 NCI 5R13CA095919-10 Workshops On Viral Oncogenesis and Pathogenesis FAN, HUNG UNIVERSITY OF CALIFORNIA IRVINE CA $5,000
Hepatitis 2011 NIDA 5R01DA016078-10 The Progression of Hepatitis C Among IDUs THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $723,353
Hepatitis 2011 NIDA 5R01DA022177-06 Opioids, HIV/HCV and Host Cell Innate Immunity HO, WENZHE TEMPLE UNIVERSITY PA $287,975
Hepatitis 2011 NIDDK 5K24DK069290-07 Patient-Oriented Research of Liver Disease CHALASANI, NAGA INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $139,676
Hepatitis 2011 NIAID 5R01AI076318-03 Inferring in vivo Capsid Assembly Kinetics from in vitro by Stochastic Simulation SCHWARTZ, RUSSELL CARNEGIE-MELLON UNIVERSITY PA $285,863
Hepatitis 2011 NCI 5R01CA122499-05 Oxidative Stress and Hepatocellular Carcinoma HUANG, TING-TING PALO ALTO INSTITUTE FOR RES & EDU, INC. CA $258,020
Hepatitis 2011 RMAP 1R21NS073933-01 Development of a HTS assay to screen for inhibitors of HCV core NS3h interactions STROSBERG, ARTHUR SCRIPPS RESEARCH INSTITUTE CA $198,000
Hepatitis 2011 NHLBI 5R44HL071373-05 DRW HIV-Ab/HCV-Ab/HBsAg Triplex Rapid Test Submission for FDA-PMA Approval LEE, HELEN DIAGNOSTICS FOR THE REAL WORLD, LTD CA $836,222
Hepatitis 2011 NIMH 5R01MH083553-04 Neurobehavioral Deficits in HIV/HCV Infection Pre/Post Anti-HCV Therapy HINKIN, CHARLES BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE CA $594,457
Hepatitis 2011 NIAID 5R01AI076259-03 Molecular determinants of hepatitis C virus infectivity LINDENBACH, BRETT YALE UNIVERSITY CT $405,516
Hepatitis 2011 NIDDK 5K08DK085432-02 Drug Induced Hepatotoxicity During Viral Hepatitis GETACHEW, YONAS UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $142,668
Hepatitis 2011 NCI 5R21CA143748-02 Regulation of hepatic NKT cells by CDld+ liver cells EXLEY, MARK BETH ISRAEL DEACONESS MEDICAL CENTER MA $183,549
Hepatitis 2011 NCI 7R03CA143656-02 Histone methyltransferase G9a in liver pathophysiology and carcinogenesis LU, HONG UPSTATE MEDICAL UNIVERSITY NY $77,358
Hepatitis 2011 NIDDK 5R01DK081410-03 Molecular Determinants of Disease Progression in Nonalcoholic Steatohepatitis SANYAL, ARUN VIRGINIA COMMONWEALTH UNIVERSITY VA $318,692
Hepatitis 2011 NIAID 5R01AI085087-02 Role of Lipids in Hepatitis C Virus Maturation SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $382,388
Hepatitis 2011 NIDDK 5R01DK082451-03 Caspase Dependent Cell Death in Nonalcoholic Fatty Liver Disease FELDSTEIN, ARIEL CLEVELAND CLINIC LERNER COL/MED-CWRU OH $334,680
Hepatitis 2011 NCI 5R01CA138635-02 Multiple Tumor Antigen-loaded DC Vaccine for Hepatocellular Cancer BUTTERFIELD, LISA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $291,196
Hepatitis 2011 NCI 5R01CA127228-05 Mechanisms of PDGF-C Induced Hepatocellular Carcinogenesis CAMPBELL, JEAN UNIVERSITY OF WASHINGTON WA $287,508
Hepatitis 2011 NIDDK 5R01DK075274-06 Mouse model of chronic viral hepatitis CRISPE, IAN SEATTLE BIOMEDICAL RESEARCH INSTITUTE WA $375,925
Hepatitis 2011 NIDDK 5R01DK081817-03 Innate Immunity and Hepatitis C Virus Infection RAY, RATNA SAINT LOUIS UNIVERSITY MO $314,429
Hepatitis 2011 NIDDK 5R01DK080812-03 Mechanisms of Liver Disease Progression by Hepatitis C Virus RAY, RANJIT SAINT LOUIS UNIVERSITY MO $314,429
Hepatitis 2011 NIDDK 5R01DK088787-02 Tight Junction: Gate to HCV Tropism, Therapeutics and Pathogenesis WANG, TIANYI UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $313,281
Hepatitis 2011 NIDA 5R01DA025932-04 Drug Interactions in Substance Abusers with HIV Infection FRIEDLAND, GERALD YALE UNIVERSITY CT $357,593
Hepatitis 2011 NIAID 5K23AI083099-02 CAUSES OF AND ASSOCIATIONS WITH DEATH DURING LONG TERM HAART IN AFRICA HOFFMANN, CHRISTOPHER JOHNS HOPKINS UNIVERSITY MD $134,165
Hepatitis 2011 NIGMS 5R01GM081346-04 Structural basis of protein synthesis by the hepatitis C virus IRES RNA KIEFT, JEFFREY UNIVERSITY OF COLORADO DENVER CO $187,027
Hepatitis 2011 NIDA 5K23DA020383-04 Buprenorphine as a Bridge to HCV Treatment for HIV/HCV Coinfected Opioid Users TAYLOR, LYNN MIRIAM HOSPITAL RI $176,814
Hepatitis 2011 NIAID 5R01AI073963-04 Host Genetic Contribution to HCV Outcomes BLANTON, RONALD CASE WESTERN RESERVE UNIVERSITY OH $519,913
Hepatitis 2011 NCI 5R03CA153099-02 Inflammation Variants and Risk of Hepatocellular Carcinoma in HBV Patients YANG, HUSHAN THOMAS JEFFERSON UNIVERSITY PA $75,175
Hepatitis 2011 NIDDK 1R01DK088940-01A1 Aerobic fitness, mitochondrial dysfunction, and fatty liver disease THYFAULT, JOHN UNIVERSITY OF MISSOURI-COLUMBIA MO $357,156
Hepatitis 2011 NIGMS 5R01GM066978-08 Structure, dynamics, and function of the viroporins Vpu from HIV and p7 from HCV OPELLA, STANLEY UNIVERSITY OF CALIFORNIA SAN DIEGO CA $296,802
Hepatitis 2011 NIAID 5R01AI090119-02 Regulated Intramembrane Proteolysis of CREB3L1 in Innate Antiviral Response YE, JIN UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $392,288
Hepatitis 2011 NIGMS 2R37GM056207-15 Simulation of Proton and Hydride Transfer in Enzymes HAMMES-SCHIFFER, SHARON PENNSYLVANIA STATE UNIVERSITY-UNIV PARK PA $284,869
Hepatitis 2011 NIDDK 1R01DK087696-01A1 The Role of Iron in the Pathogenesis of NAFLD KOWDLEY, KRIS BENAROYA RESEARCH INST AT VIRGINIA MASON WA $773,137
Hepatitis 2011 RMAP 5RL1DK081187-05 Dietary Micronutrients & Weight Loss in Liver Metabolism & Fat Content in Humans PARKS, ELIZABETH UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $424,817
Hepatitis 2011 NIMH 5R01MH090250-02 Vulnerability to major depression: The role of delta sleep in patients receiving LOTRICH, FRANCIS UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $315,596
Hepatitis 2011 NIAID 5F32AI091207-02 Characterization and Consequences of HCV Interaction with Host Lipoproteins SCULL, MARGARET ROCKEFELLER UNIVERSITY NY $48,398
Hepatitis 2011 NIDDK 1R01DK090066-01A1 Role of PNPLA3 in Fatty Liver Disease HOBBS, HELEN UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $364,550
Hepatitis 2011 NIAID 1R01AI089957-01A1 Novel antiviral activities of tumor necrosis factor-alpha DUSTIN, LYNN ROCKEFELLER UNIVERSITY NY $423,750
Hepatitis 2011 NIAID 1R01AI091707-01A1 Type I interferon-stimulated genes and the antiviral immune response RICE, CHARLES ROCKEFELLER UNIVERSITY NY $422,500
Hepatitis 2011 NIAID 2R01AI071068-06 RNAi for the Treatment of Viral Hepatitis KAY, MARK STANFORD UNIVERSITY CA $453,945
Hepatitis 2011 NIAID 1R01AI094409-01 Antisense Mediated Treatment of Hepatitis B Virus Infection WIELAND, STEFAN SCRIPPS RESEARCH INSTITUTE CA $816,540
Hepatitis 2011 NIDDK 5U01DK061713-10 NASH Clinical Research Network DIEHL, ANNA MAE DUKE UNIVERSITY NC $470,848
Hepatitis 2011 NIDDK 5U01DK061718-10 The Saint Louis University Component of the NASH Clinical Research Network NEUSCHWANDER-TETRI, BRENT SAINT LOUIS UNIVERSITY MO $313,273
Hepatitis 2011 NIDDK 5U01DK061730-10 Continuation of the Non-Alcoholic Steatohepatitis Clinical Research Network TONASCIA, JAMES JOHNS HOPKINS UNIVERSITY MD $1,029,811
Hepatitis 2011 NIDDK 5U01DK061732-10 Clincal Research Network in Non-Alcoholic Steatohepatitis (NASH CRN) MCCULLOUGH, ARTHUR CLEVELAND CLINIC LERNER COL/MED-CWRU OH $323,880
Hepatitis 2011 NIDDK 5U01DK061737-10 Collaborative Clinical Research on Non Alcoholic Stratohepatitis CHALASANI, NAGA INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $583,895
Hepatitis 2011 NICHD 5U01DK061734-10 Clinical Research on Nonalcoholic Fatty Liver Disease LAVINE, JOEL COLUMBIA UNIVERSITY HEALTH SCIENCES NY $495,000
Hepatitis 2011 NIDDK 5U01DK061734-10 Clinical Research on Nonalcoholic Fatty Liver Disease LAVINE, JOEL COLUMBIA UNIVERSITY HEALTH SCIENCES NY $526,433
Hepatitis 2011 NIDDK 5U01DK061738-10 Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network TERRAULT, NORAH UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $270,864
Hepatitis 2011 NIDA 5R01DA023405-05 HIV and HIV/HCV-Infection, Disease Progression, Oxidative Stress and Antioxidants BAUM, MARIANNA FLORIDA INTERNATIONAL UNIVERSITY FL $637,960
Hepatitis 2011 NIAID 5R01AI079060-03 Immunological Priming to Hepatitis B Virus ISOGAWA, MASANORI SCRIPPS RESEARCH INSTITUTE CA $465,302
Hepatitis 2011 NCI 5R01CA134245-04 Evaluation of a Hepatitis B Outreach Intervention for Cambodians TAYLOR, VICTORIA FRED HUTCHINSON CANCER RESEARCH CENTER WA $13,756
Hepatitis 2011 NIAID 1R01AI094469-01 Preclinical Development of SB 44 as an Orally Bioavailable Anti-HBV Agent IYER, RADHAKRISHNAN SPRING BANK TECHNOLOGIES, INC. MA $765,000
Hepatitis 2011 NIAID 1R01AI094474-01 Development of a novel drug candidate that inhibits hepatitis B virus covalently GUO, HAITAO DREXEL UNIVERSITY PA $824,100
Hepatitis 2011 NCI 5R01CA039416-26 Molecular Mechanisms of Chemoprevention: NRF2 Signaling KENSLER, THOMAS UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $494,232
Hepatitis 2011 NIDDK 5R21DK091357-02 Crystal structure of signal peptide peptidase with engineered antibody fragment LIEBERMAN, RAQUEL GEORGIA INSTITUTE OF TECHNOLOGY GA $213,061
Hepatitis 2011 NIDA 5R01DA024565-05 Mechanisms of Hepatitis C Virus Evolution RAY, STUART JOHNS HOPKINS UNIVERSITY MD $527,079
Hepatitis 2011 NIDDK 5U01DK061731-10 Nonalcoholic Steatohepatitis Clinical Research Network SANYAL, ARUN VIRGINIA COMMONWEALTH UNIVERSITY VA $534,941
Hepatitis 2011 NCI 5R01CA129763-05 A Randomized Trial of Hep B Screening and Vaccination in High Risk Vietnamese MA, GRACE TEMPLE UNIVERSITY PA $1
Hepatitis 2011 NIAID 5R01AI080734-03 HCV Genotype 6: A Model for HCV Genetics and Molecular Epidemiology Studies LU, LING UNIVERSITY OF KANSAS MEDICAL CENTER KS $371,250
Hepatitis 2011 NIDDK 5R01DK082583-02 MLK3 in metabolic stress signaling JAESCHKE, ANJA UNIVERSITY OF CINCINNATI OH $322,517
Hepatitis 2011 NIDDK 5K23DK077568-05 Kidney Disease in HIV-Hepatitis C Virus Co-Infection WYATT, CHRISTINA MOUNT SINAI SCHOOL OF MEDICINE NY $129,465
Hepatitis 2011 NIMH 5R01MH092225-02 Clinical Trial of CNS Penetrating ART to Prevent NeuroAIDS in China LETENDRE, SCOTT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $533,855
Hepatitis 2011 NCI 5R25CA129042-04 Asian American Liver Cancer Education Program in Maryland JUON, HEE-SOON JOHNS HOPKINS UNIVERSITY MD $274,632
Hepatitis 2011 NIAID 5R01AI077757-03 Mechanisms of Immune Evasion by Hepatitis C Virus COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $401,841
Hepatitis 2011 NIDDK 5R01DK061498-10 Role of CYP2E1 in the Progression to NASH CZAJA, MARK ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $326,857
Hepatitis 2011 NINDS 5K23NS051244-05 Relationship of Cytokines to Cognitive Functions in HCV HILSABECK, ROBIN UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT TX $167,980
Hepatitis 2011 NIDDK 5K23DK089004-02 An Adherence and Depression Intervention for Patients During Hepatitis C Therapy EVON, DONNA UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $140,494
Hepatitis 2011 NIDDK 5U01DK061728-11 Clinical Research Network in Non-Alcoholic Steatohepatitis KOWDLEY, KRIS BENAROYA RESEARCH INST AT VIRGINIA MASON WA $446,055
Hepatitis 2011 NIAAA 5R37AA010154-16 TNF Alpha and Recovery from Alchoholic Liver Injury DIEHL, ANNA MAE DUKE UNIVERSITY NC $365,257
Hepatitis 2011 NCI 1R21CA141105-01A2 Hepatitis D virus genomic RNA in the etiology of liver cancer GAREN, ALAN YALE UNIVERSITY CT $216,086
Hepatitis 2011 NIDDK 1R21DK089314-01A1 Coronavirus modulation of cellular microRNAs in the liver: role in hepatitis NAVAS-MARTIN, SONIA DREXEL UNIVERSITY PA $231,750
Hepatitis 2011 NIDDK 5R01DK089185-02 Mechanisms and metabolic implications of LRP130 in NAFLD COOPER, MARCUS UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $354,210
Hepatitis 2011 NCI 1R21CA152514-01A1 HCV Strain Variation and HCC BRANCH, ANDREA MOUNT SINAI SCHOOL OF MEDICINE NY $221,198
Hepatitis 2011 NIGMS 2R01GM083257-03A1 Small Molecule Tools to Image Sophisticated Protein Function SCHEPARTZ, ALANNA YALE UNIVERSITY CT $288,585
Hepatitis 2011 NHLBI 5R01HL095136-04 Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans FREIBERG, MATTHEW UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $986,138
Hepatitis 2011 NCI 5R21CA152589-02 Sex Chromosomes and Gender Disparity in HBV-Related Hepatocellular Carcinoma LAU, YUN-FAI CHRIS NORTHERN CALIFORNIA INSTITUTE RES & EDUC CA $125,066
Hepatitis 2011 NIDA 5R01DA027379-03 Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs SCHACKMAN, BRUCE WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $498,584
Hepatitis 2011 NIDDK 5R01DK087877-02 Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCV TAOULI, BACHIR MOUNT SINAI SCHOOL OF MEDICINE NY $337,950
Hepatitis 2011 NCI 5R01CA138698-02 Epidemiologic Study of Hepatocellular Carcinoma in the US YU, HERBERT YALE UNIVERSITY CT $537,816
Hepatitis 2011 NIGMS 5R01GM087738-04 Inhibition of HCV as an Opportunistic HIV Co-infection FISHBEIN, JAMES UNIVERSITY OF MARYLAND BALT CO CAMPUS MD $330,727
Hepatitis 2011 NIAID 5K08AI079406-04 Novel antviral targets in Hepatitis C virus NS4B protein EINAV, SHIRIT STANFORD UNIVERSITY CA $130,599
Hepatitis 2011 NHLBI 5R01HL067229-10 Transfusion Infection Pediatric Prospective Study (TRIPPS) LUBAN, NAOMI CHILDREN'S RESEARCH INSTITUTE DC $332,000
Hepatitis 2011 NIAID 5R01AI079150-03 Cyclosporine, Cyclophilins and HCV Replication TANG, HENGLI FLORIDA STATE UNIVERSITY FL $321,298
Hepatitis 2011 NIAID 5K24AI083742-03 Midcareer Investigator Award in Patient-Oriented Research (K24) ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $191,392
Hepatitis 2011 NCI 5U01CA143072-03 Molecular Determinants of Tumor Progression in A Steatolic Liver Microenvironment GORDEN, DAVID VANDERBILT UNIVERSITY TN $299,787
Hepatitis 2011 NIAID 1R43AI094732-01 Selection of the Optimal Nucleoside Triphosphate Mimic Prodrug Inhibitor of HCV R COOK, PHILLIP R. I. CHEMICAL, INC. CA $300,000
Hepatitis 2011 NIAID 1R13AI094884-01 2011 International Meeting on the Molecular Biology of Hepatitis B Viruses ROBEK, MICHAEL HEPATITIS B FOUNDATION PA $15,000
Hepatitis 2011 NIDDK 1R13AI094884-01 2011 International Meeting on the Molecular Biology of Hepatitis B Viruses ROBEK, MICHAEL HEPATITIS B FOUNDATION PA $5,000
Hepatitis 2011 NIDDK 5K24DK078772-05 Patient-Oriented Research on Hepatitis in Special Populations CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $165,243
Hepatitis 2011 NCI 5K24CA139570-02 A Multidisciplinary and Translational Approach to Hepatobiliary Malignancy NELSON, DAVID UNIVERSITY OF FLORIDA FL $186,940
Hepatitis 2011 NCI 5R01CA153073-02 The Effect of Aflatoxin Regulation on Global Liver Cancer Risk WU, FELICIA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $233,389
Hepatitis 2011 NIDDK 5R01DK076986-05 Integrative genomic analysis in hepatocellular carcinoma LLOVET, JOSEP MOUNT SINAI SCHOOL OF MEDICINE NY $242,852
Hepatitis 2011 NIDDK 5R01DK074487-05 Proteomic profiling of NASH: disease mechanisms and novel treatment PETERSEN, DENNIS UNIVERSITY OF COLORADO DENVER CO $300,742
Hepatitis 2011 NIDDK 5R21DK089456-02 Quantifying risk from and appropriate recipients for infectious-risk kidneys SEGEV, DORRY JOHNS HOPKINS UNIVERSITY MD $240,199
Hepatitis 2011 NIAAA 9R42AA021228-02A1 Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease KLETZIEN, ROLF METABOLIC SOLUTIONS DEVELOPMENT CO MI $563,804
Hepatitis 2011 NIAID 2R42AI088793-03 Advancing clemizole for hepatitis C: towards a pre-IND package--Phase II MURPHY, BRIAN EIGER GROUP INTERNATIONAL, INC. CA $1,000,000
123


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer